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istrating appropriate supportive treatment which in turn lead to
decreased hospitalization rate and reduce healthcare cost.
http://dx.doi.org/10.1016/j.ijid.2012.05.23915th ICID Abstracts / International Journ
roup B-105iu/L (SD-91.5) (p=0.002). None of the symptoms, signs
nd other investigations including platelet count, packed cell vol-
me (PCV) and white blood cell count was signiﬁcantly different.
nalysis of the whole 117, pearson correlation test showed a pos-
tive correlation of AST(r=0.3) (p=0.038) and ALT(r=0.3) (P=0.045)
ith PCV and a negative correlation (r=-0.3) with platelet count
p=0.014). AST(r=0.25) and ALT (r=0.3) on day 3 was positively cor-
elated with development of malena at any stage (p=0.05).
Conclusion: Higher AST and ALT levels on 3rd day of dengue
eems to be useful predictors of severe dengue.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.237
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henotypic and functional characterization of human  T cell
ubsets in response to inﬂuenza A viruses
. Qin1,∗, Y. Liu2, J. Zheng2, Z. Xiang2, I.H. Ng2, M. Peiris2, Y.-L.
au2, W. Tu2
Nantong University, China, Nantong, China
The University of Hong Kong, Hong Kong, China
Background: It has become increasingly clear that  T cells
re important components in both innate and adaptive immune
ystems, yet the cellular requirement for the activation of  T
ells is still poorly deﬁned. Like  T cells, human V9V2 T cells
ay be divided into four subsets: naive, central memory, effector
emory and terminal differentiated cells, according to their sur-
ace expression of CD45RA and CD27. Whether human V9V2 T
ells have functionally different subsets in response to inﬂuenza A
ﬂuA) viruses remains unknown.
Methods: Here we applied ﬂuA virus-infected primary human
onocyte-derived macrophages (MDMs) for examining the
ntiviral activity of phosphoantigen isopentenyl pyrophosphate
IPP)-expanded human V9V2 cells against inﬂuenza viruses. Dif-
erent  T subsets were sorted with FACS Aria-II dependent on
he surface expression levels of CD27 or CD56. Flow cytometry
as used for phenotyping, cytotoxic assay and cytokine quantiﬁ-
ation. Speciﬁc blocking antibodies were utilized to uncover the
echanisms for -T-mediated cytolytic antiviral effects.
Results: In this study, we demonstrated that both central
CD45RA-CD27+) and effector (CD45RA-CD27-) memory V9V2
had similar levels of immediate IFN- and cytotoxic responses
o human and avian ﬂuA virus-infected cells. In contrast, CD56+
9V2 T cells had signiﬁcantly higher cytotoxicity against ﬂuA
irus-infected cells, comparedwithCD56- counterparts,while both
ubsets had similar IFN- responses.We further demonstrated that
he CD16-dependant degranulation pathway, but not antibody-
ependent cell-mediated cytotoxicity (ADCC), contributed to the
uperior cytotoxicity of CD56+ V9V2 T cells.
Conclusion:Our study provides further evidence for the pheno-
ypic and functional characterization of human V9V2 T subsets
uring ﬂuA virus infection, and may help improve the  T
ell-based immunotherapy for viral infection. As  T cell-based
mmunotherapyhas been showed a great potential for treating ﬂuA
nfection, our ﬁndings may help improve its efﬁcacy for the control
f viral infection.nfectious Diseases 16S (2012) e2–e157 e103
http://dx.doi.org/10.1016/j.ijid.2012.05.238
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Hemorrhagic Fever From Dengue Fever
B. Raghavan ∗, M.L. Ng
National University of Singapore, Singapore, Singapore
Background: Dengue virus (DENV) infection is a re-emerging
infectious disease that accounts for hundred million cases annu-
ally. However, there are no vaccine and effective therapeutic
options currently available. Early recognition and prompt sup-
portive treatment can help to lower the risk of developing severe
disease complications such as Dengue Hemorrhagic Fever/Dengue
Shock Syndrome (DHF/DSS). Hence there is an urge to identify the
biomarkers linkedwithDHF/DSS. Thus, this study aimed to identify
potential biomarkers that are linked with varying degrees of dis-
ease severity and capable of differentiating Dengue Hemorrhagic
Fever/Dengue Shock Syndrome (DHF/DSS) and Dengue fever (DF).
Methods: The sera samples collected fromdenguepatientswith
varying degrees of disease severity DF, DHF and DSS) were used to
probe the protoarray chips containing 9000 human proteins (Invit-
rogen). The sera samples were collected at three different time
points from each patient (ﬁrst sample: 1-4 days; second sample:
5-7 days; third sample: 21 days). After probing with appropri-
ate antibodies, the protoarray chips were scanned in a microarray
scanner. Data analysis was performed using protoarray prospector
software (Invitrogen).
Results: A wide range of proteins involved in signal transduc-
tion, membrane permeability, intracellular trafﬁcking, enzymatic
activity, transcription, muscle functions, immune response and
apoptosis were found to be stimulated during dengue infection.
Interestingly, proteins related to vascular permeability (EGF-
like domain-containing protein 7, -macroglobulin and vascular
endothelial growth factor) were identiﬁed in DHF sera. Although,
these results were derived from 14 dengue sera, the results were
consistent. The authenticity of the identiﬁed biomarkers were ana-
lysedusing 100-150 serumsamples obtained fromDenguepatients
with varying degrees of disease severity. The results reafﬁrmed
that vascular endothelial growth factor and -macroglobulin were
present at a signiﬁcantly higher quantities (P<0.05) in the serum
samples of DHF/DSS patients compared to that of DF patients. This
assures that vascular endothelial growth factor and-macroglobulin
can be used as biomarkers to differentiate DHF/DSS from DF.
Conclusion: Identiﬁcation of these attractive biomarkers
associated with severe disease development would help in admin-
